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Purpose: Genetic polymorphisms have been associated with the adaptation to training in 
maximal oxygen uptake (V̇O2max). However, the genotype distribution of selected 
polymorphisms in athletic cohorts is unknown, with their influence on performance 
characteristics also undetermined. This study investigated whether the genotype distributions 
of three polymorphisms previously associated with V̇O2max training adaptation are associated 
with elite athlete status and performance characteristics in runners and rugby athletes, 
competitors for whom aerobic metabolism is important.  
Methods: Genomic DNA was collected from 732 men, including 165 long-distance runners, 
212 elite rugby union athletes and 355 non-athletes. Genotype and allele frequencies of 
PRDM1 rs10499043 C/T, GRIN3A rs1535628 G/A and KCNH8 rs4973706 T/C were compared 
between athletes and non-athletes. Personal best marathon times in runners, as well as in-game 
performance variables and playing position of rugby athletes, were analysed according to 
genotype. 
Results: Runners with PRDM1 T alleles recorded marathon times ~3 min faster than CC 
homozygotes (02:27:55 ± 00:07:32 h vs. 02:31:03 ± 00:08:24 h, p = 0.023). Rugby athletes had 
1.57 times greater odds of possessing the KCNH8 TT genotype than non-athletes (65.5% vs. 
54.7%, χ2 = 6.494, p = 0.013). No other associations were identified. 
Conclusions: This study is the first to demonstrate that polymorphisms previously associated 
with V̇O2max training adaptations in non-athletes are also associated with marathon 
performance (PRDM1) and elite rugby union status (KCNH8). The genotypes and alleles 
previously associated with superior endurance training adaptation appear to be advantageous 
in long-distance running and achieving elite status in rugby union. 
 




Exercise-related phenotypes are determined by the interaction of genetics and the environment. 
1 For many phenotypes, individual differences remain when environmental factors are 
controlled, highlighting the important contribution of heritable factors.2 The discovery of genes 
and common genetic variants that are associated with quantifiable phenotypes can, therefore, 
help to elucidate the mechanisms that contribute to such individual differences.  
 Cardiorespiratory fitness is positively associated with health outcomes and can be 
improved by regular aerobic activity.3 The maximal rate of O2 uptake (V̇O2max) describes the 
maximal amount of O2 per unit of time that can be delivered to peripheral organs, such as 
skeletal muscle, and is the standard measurement of cardiorespiratory fitness.4 Findings from 
the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study estimate 
that the heritability of V̇O2max in the untrained state is approximately 50%.5 A subsequent 
report involving the same cohort estimated the heritability of the adaptation of V̇O2max 
following a 20-week endurance training program to be 47%.2 These data suggest that not only 
are some individuals predisposed to superior cardiovascular fitness in the absence of exercise 
stimuli, but that the magnitude to which an individual can adapt to aerobic exercise training is 
also genetically influenced.  
The benefit of cardiorespiratory fitness to athletic performance is reflected by superior 
V̇O2max amongst athletes compared to non-athletes and may be explained, in part, by the 
deliberate exposure of athletes to prolonged exercise training.4 It is also possible that 
individuals with genetic variants that predispose them to better training adaptation are more 
likely to reach the elite level, because they can improve their baseline cardiorespiratory fitness 
to a greater magnitude than those with less favourable genetics. The association of specific 
polymorphisms with athlete status, through the overrepresentation of a particular genotype 
compared to the general population, supports the notion that genetic variation can enhance an 
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individual’s chances of becoming an elite athlete.6 Indeed, there are specific genotypes that are 
more common amongst elite endurance athletes7 and elite athletes from team sports such as 
rugby8,9 and soccer10 than the general population. Nonetheless, the polygenic nature of 
physiological traits means that the discovery of additional variants remains key to 
understanding the genetic contribution to athletic performance. Once new associations are 
discovered between specific variants and traits of interest, it is important that researchers can 
independently replicate those findings. Reproducible data reduces the risk of false positive 
results based on single studies, and subsequently helps identify genes and/or variants for further 
mechanistic investigation regarding their functional consequences on physiological processes.  
After determining the heritability of V̇O2max training adaptations, Bouchard and 
colleagues performed a Genome Wide Association Study (GWAS) to identify genomic loci 
associated with the variance in training adaptation.11 Twenty-one single nucleotide 
polymorphisms (SNPs) were individually associated with the magnitude of V̇O2max 
improvement, and in combination explained 48.6% of the variance in adaptation between 
individuals. The three SNPs contributing the most to inter-individual differences in V̇O2max 
training adaptation were PR/SET domain 1 (PRDM1) rs10499043 C/T (7.0%), glutamate 
ionotropic receptor NMDA type subunit 3A (GRIN3A) rs1535628 G/A (5.2%), and potassium 
voltage-gated channel subfamily H member 8 (KCNH8) rs4973706 T/C (4.5%). However, to 
our knowledge, no study has sought to replicate these associations or investigate whether the 
distribution of those genotypes associated with V̇O2max training adaptation differs between the 
general population and groups where enhanced training adaptations may be advantageous, such 
as elite athletes. In addition, team sports such as rugby union include different playing positions 
with variable match demands12,13 and differences in aerobic performance between these 
positions.14 Some athletes may, therefore, have an inherited benefit of an enhanced capacity 
for cardiorespiratory adaptation. Furthermore, the relationship between estimated V̇O2max and 
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the effects of fatigue on tackling technique in rugby league15 suggests cardiorespiratory fitness 
could be an important contributor to match outcomes. However, it is not known whether in-
game performance variables are associated with genetic variability.  
Thus, the purpose of the present study was to determine whether three SNPs previously 
related to V̇O2max training adaptation are associated with elite athlete status amongst long-
distance runners and rugby union athletes, and whether genotypes of these SNPs are associated 
with long-distance running and elite rugby union performance. We hypothesised that the alleles 
associated with greater training adaptations of V̇O2max (PRDM1 T allele, GRIN3A A allele 
and KCNH8 T allele) would (i) be overrepresented in athletes compared to the general 
population, (ii) be associated with superior performance amongst long-distance runners and 
favourable in-game performance in rugby union athletes, and (iii) differ in frequency according 





This study recruited 732 Caucasian male participants including 212 rugby athletes, 165 long-
distance runners and 355 healthy non-athletes. Rugby athletes all competed in rugby union and 
included 73.1% British, 14.2% South African and 10.4% Irish, with other nationalities each 
contributing 0.5%. All rugby athletes were considered elite having competed regularly (>5 
matches) since 1995 in the highest professional league in the UK, Ireland or South Africa, and 
were recruited as part of the RugbyGene Project (described in detail by Heffernan and 
colleagues16). Of these athletes, 53.8% had competed at international level, with 99.1% of those 
representing a “High Performance Union” (Regulation 16, www.worldrugby.org). Long-
distance runners were primarily recruited from the London Marathon Expo between 2012 and 
2014, in addition to national/regional athletic clubs and organisations in the UK. Runners 
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included 91.5% British and 1.2% Polish, with other nationalities each contributing 0.5%. The 
inclusion criterion for runners was a personal best (PB) marathon time of ≤ 3 hours verified 
using official online records (www.thepowerof10.info). Non-athlete participants were 355 
healthy, unrelated recreationally active males recruited through mail-outs, posters and word of 
mouth. Due to assay availability, KCNH8 rs4973706 genotype data was only available for 362 
participants, including 139 rugby athletes and 223 non-athletes. Participant characteristics are 
described in Table 1. This study was conducted in accordance with the Declaration of Helsinki 




Blood (~68% of samples), buccal swab (~23%) or saliva (~9%) samples were obtained via the 
following protocols. Blood was drawn from a superficial forearm vein into an EDTA tube and 
stored in sterile tubes at -20°C until processed. Saliva samples were collected into Oragene 
DNA OG-500 collection tubes (DNA Genotek, Ottawa, Ontario, Canada) according to the 
manufacturer’s protocol and stored at room temperature until processed. Sterile buccal swabs 
(Omni swab; Whatman, Springfield, Mill, UK) were rubbed against the buccal mucosa of the 
cheek for ~30 s. Tips were ejected into sterile tubes and stored at -20°C until processed. 
 
DNA isolation 
DNA isolation was performed using a QIAamp DNA Blood Mini kit and standard spin column 
protocol according to manufacturer instructions (Qiagen, West Sussex, UK). Briefly, 200 µL 
of whole blood/saliva, or one buccal swab, was lysed and incubated, the DNA washed, and the 





Samples were genotyped for the PRDM1 (rs10499043 C/T), GRIN3A (rs1535628 G/A) and 
KCNH8 (rs4973706 T/C) SNPs by combining 5 µL Genotyping Master Mix (Applied 
Biosystems, Paisley, UK), 4.3 µL H2O, 0.5 µL assay mix (Applied Biosystems), and 0.2 µL of 
purified DNA (~9 ng), for samples derived from blood and saliva. For DNA derived from 
buccal swabs, 5 µL Genotyping Master Mix was combined with 3.5 µL H2O, 0.5 µL assay mix, 
and 1 µL DNA solution (~9 ng DNA). Either a Chromo4 (Bio-Rad, Hertfordshire, UK) or a 
StepOnePlus real-time system (Applied Biosystems) was used. Briefly, denaturation began at 
95°C for 10 min, with 40 cycles of incubation at 92°C for 15 s before annealing and extension 
at 60°C for 1 min. Initial genotyping analysis was performed with Opticon Monitor software 
version 3.1 (Bio-Rad) or StepOnePlus software version 2.3 (Applied Biosystems). All samples 
were analysed in duplicate and were in 100% agreement.  
 
Rugby union positional groups 
To further assess genotype and allele frequencies in rugby union, athletes were allocated to 
subgroups: forwards (props, hookers, locks, flankers, number eights) and backs (scrum halves, 
fly halves, centres, wingers, full backs). Due to diverse physiological demands within rugby 
union, athletes were further divided into positional groups based on similarities in their 
movement patterns12 as front five (props, hookers, locks), back row (flankers, number eights), 
half backs (scrum halves, fly halves), centres, and back three (wings and full backs). The rugby 
athletes’ playing positions are shown in Table 2. 
 
Rugby union in-game performance variables 
In-game performance data for 112 of the 212 rugby athletes was obtained from Opta Sports 
(London, UK) for all matches during eight seasons (2012-13 to 2019-20) of rugby union 
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competition in the highest professional competitive leagues in England (Premiership) and 
Wales/Ireland/Scotland/Italy/South Africa (Celtic/PRO12/PRO14). Athletes were included for 
analysis where performance data were available for a minimum of 320 competitive minutes, 
equivalent to 39.9 ± 27.0 80-min matches per player. The analysed variables were: number of 
carries per 80 min; metres gained in possession per 80 min; number of penalties conceded per 




Statistical analyses were conducted using SPSS for Windows version 25.0 (IBM Statistics, 
Chicago, Illinois). Genotype distributions and allele frequencies of athletes versus non-athletes, 
athlete sub-groups, and of athlete sub-groups versus non-athletes, were compared by χ2 
goodness-of-fit test. Genotype distribution was analysed using additive (AA vs. Aa vs. aa) and 
recessive (AA vs. Aa+aa) models due to low minor allele frequencies. Odds ratios (OR) were 
calculated where genotype distribution differed between groups. Genotype distribution and 
allele frequencies according to rugby playing position were compared using the χ2 test of 
independence. The associations of PRDM1 and GRIN3A genotypes with long-distance runners’ 
PB marathon time were analysed in a recessive model only (due to low minor allele frequency) 
by independent samples t-test. Performance variables were compared between rugby union 
forwards and backs by independent samples t-test. The association between PRDM1 (n = 112), 
GRIN3A (n = 112) and KCNH8 (n = 95) genotype and rugby union in-game performance 
variables were analysed in a recessive model only (due to low minor allele frequency) by one-
way ANCOVA, with first rugby union subgroups (forwards and backs), then positional groups 
(front five, back row, half backs, centres and back three), as covariates. P values < 0.05 were 
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considered statistically significant, after Bonferroni adjustment for multiple comparisons. All 
data are presented as mean ± standard deviation. 
 
Results 
Hardy Weinberg Equilibrium (HWE) and Genotype distribution 
Genotype distributions across all groups for each SNP are described in Table 3. All were in 
HWE (χ2  0.773, p ≥ 0.379). Although not statistically significant (p = 0.056, OR = 1.27 (95% 
confidence intervals (CI) 0.89-1.79)), 24.7% of all athletes carried the PRDM1 T allele 
(CT/TT) compared to 20.6% of non-athletes. Similarly, although not statistically significant (p 
= 0.054, OR = 1.44 (95% CI 0.91-2.16), 26.7% of runners carried one or more T allele 
compared to 20.6% of non-athletes. KCNH8 TT genotype was overrepresented in rugby 
athletes compared to non-athletes (65.5% vs. 54.7%, χ2 = 6.494, p = 0.013, OR = 1.57 (95% CI 
1.01-2.43), Fig. 1). There were no other differences in genotype frequencies between groups 
(p ≥ 0.148). 
 
Runner PB marathon times 
Runners with the PRDM1 T allele (CT/TT) had ~3 min faster PB marathon times than those 
with the CC genotype (02:27:55 ± 00:07:31 h vs. 02:31:03 ± 00:08:24 h, p = 0.023; Fig. 2). 
There were four T allele carriers (CT/TT) amongst the 10 fastest runners, with a T allele 
frequency of 0.25 in those 10 compared to 0.13 in the remaining 155 runners. However, there 
was no overall association between PB marathon time and GRIN3A genotype. 
 
Rugby union positional groups 
No differences in genotype distribution were observed between forwards and backs for PRDM1 
(T allele carriers 22.0% vs. 24.5 respectively, p = 0.744), GRIN3A (A allele carriers 18.4% vs. 
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16.3%, p = 0.720) and KCNH8 (C allele carriers 29.1% vs. 41.7%, p = 0.150). Similarly, no 
differences in PRDM1, GRIN3A or KCNH8 genotype distribution were observed according to 
rugby athletes’ playing position (p ≥ 0.228). 
 
Rugby union in-game performance variables 
There was no association of genotype with in-game performance variables adjusted for playing 
position (p ≥ 0.131). Regardless of genotype, backs carried the ball forward for a greater 
distance per 80 min than forwards (32.2 ± 15.0 m vs 12.5 ± 11.0 m, p < 0.0005). Compared to 
backs, forwards completed more successful tackles per 80 min (9.8 ± 2.1 vs 5.9 ± 2.3, p < 
0.0005), had a higher percentage of successful tackles (89.7 ± 4.14 vs 82.9 ± 6.7, p < 0.0005) 
and conceded more penalties per 80 min (1.0 ± 0.5 vs 0.4 ± 0.2, p < 0.0005). Performance data 
are not presented. 
 
Discussion 
The aim of this study was to determine whether three SNPs previously linked to V̇O2max 
training adaptations were associated with athlete status and performance characteristics in elite 
rugby athletes and long-distance runners. The main findings were that in runners, the PRDM1 
T allele was associated with faster marathon running times and tended to be overrepresented 
compared to non-athletes, and that elite rugby athletes had 1.57 times greater odds of 
possessing the KCNH8 TT genotype than non-athletes. These findings confirm our primary 
hypothesis, that the alleles and genotypes associated with athlete status and athletic 
performance in the present study align with those previously associated with greater V̇O2max 
improvement.11 In contrast, the GRIN3A SNP was not associated with any of the variables 
investigated in this study, suggesting it does not affect elite status or performance in runners or 
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rugby athletes, whilst there was no relationship between any SNP and rugby union in-game 
performance variables. 
Runners with the PRDM1 CT/TT genotype recorded ~3 min (2.1%) faster personal best 
marathon times than CC homozygotes, suggesting that carrying at least one PRDM1 T allele is 
favourable to endurance running performance. The T allele also tended to be more common 
amongst runners than non-athletes. The rs10499043 SNP is a C>T substitution located 287 kb 
from PRDM1, previously known as BLIMP1, which encodes a protein that represses β-
interferon gene expression and may be involved in skeletal muscle fiber differentiation,17 
although that has not been shown in human tissue. PRDM1 may also be a target of epigenetic 
downregulation,18 though a functional link to cardiorespiratory fitness is unknown. Whilst 
V̇O2max was not measured in this study, our finding that runners with the PRDM1 T allele 
recorded faster personal best marathon times than CC homozygotes (02:27:55 h vs 02:31:03 h) 
suggests that a genetic predisposition to achieve greater training-induced improvements in 
V̇O2max might contribute to superior running performance. Indeed, the PRDM1 T allele and 
CT/TT genotype were more frequent in the 10 fastest runners than in the remaining runners 
(25.0% vs 13.2%, and 40.0% vs 25.8%, respectively). Nevertheless, 73.3% of runners in this 
study, all of whom recorded marathon times below 03:00:00 h, did not carry the PRDM1 T 
allele. These data reaffirm the notion that while high-level marathon performance is dependent 
on several factors including major and obvious environmental ones like training volume, some 
of the variation in marathon performance at high levels of the sport could be genetically 
influenced.19,20 When considered alongside the superior V̇O2max improvements in TT 
homozygotes and the proportion of V̇O2max improvement attributed to this SNP,11 our findings 
suggest further investigation of this SNP in human endurance performance is warranted. If 
replicated in independent populations, in vitro studies should seek to determine a functional 
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link between PRDM1 rs10499043 and relevant biology including aspects of muscle 
differentiation.  
In a sub-sample of the study cohort, the KCNH8 TT genotype was overrepresented in 
elite rugby athletes compared to non-athletes. The rs4973706 SNP is a T>C substitution located 
268kb from KCNH8, which is principally expressed within the human nervous system.21 
KCNH8 includes a potassium voltage-gated channel and is a member of the human Elk K+ 
channel gene family,22 which has diverse functions including regulating heart rate, insulin 
secretion, neurotransmitter release and epithelial electrolyte transport.22 Due to association of 
the TT genotype with greater V̇O2max adaptation,11 and the importance of aerobic fitness to 
repeated-effort performance of rugby league athletes,23 we hypothesised an overrepresentation 
of the TT genotype in rugby union athletes compared to non-athletes. Indeed, cardiorespiratory 
fitness contributes to elite rugby union performance,13,24 and endurance training is fundamental 
to elite clubs’ athlete preparation.25 Consequently, heritable factors predisposing a greater 
magnitude of V̇O2max improvement during training likely contribute to athletes’ ability to 
reach the highest level of competition in rugby union. The association described in the present 
study is the first association of this SNP with elite rugby status, and whilst rugby athletes had 
1.57 times greater odds of possessing the TT genotype than non-athletes, ~36% of rugby 
athletes in this study lack the TT genotype, demonstrating that other factors including other 
genetic variants8,9 contribute to elite rugby status. No studies have investigated the rs4973706 
variant since the association with V̇O2max improvement,11 so as far as we are aware, the 
functional role of this SNP is unknown. However, the exercise-induced rise in ATP-sensitive 
potassium channel expression, which promotes reduced cardiac energy consumption under 
escalating workloads as an adaptive response to exercise26 suggests genetic variations in 
KCNH8, a gene related to potassium channel pathways, might influence the inter-individual 
capacity for cardiorespiratory adaptation. The findings described here and the previous 
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association with V̇O2max adaptation demonstrate the need for replication in larger athletic and 
non-athletic cohorts and for mechanistic studies of the rs4973706 variant vis-à-vis cardiac 
function and V̇O2max. 
The GRIN3A rs1535628 variant was not associated with athlete status, running 
performance, rugby playing position or rugby performance variables. That SNP lies 516 kb 
upstream of GRIN3A, which is widely expressed in neural cells and involved in the 
development of synaptic elements.27 Other GRIN3A polymorphisms are associated with 
conditions such as Kawasaki disease28 and schizophrenia,29 yet the functional consequence of 
the rs1535628 SNP remains undescribed. Less than 1% of participants in the present study had 
the AA genotype previously associated with superior V̇O2max adaptation,11 with a low minor 
allele frequency across all groups potentially limiting the power to detect associations. 
Furthermore, the present study investigated runners and rugby athletes, and it is possible that 
the GRIN3A rs1535628 SNP is only associated with cardiorespiratory fitness improvement of 
non-athletes when they first begin training, as investigated in HERITAGE and the subsequent 
GWAS.11 While further studies are warranted to replicate the original association, the present 
study suggests this SNP is unlikely to influence athlete status and performance in runners or 
rugby athletes. 
No SNP was associated with rugby union playing position or in-game performance 
variables in the present study. We hypothesised that differences would exist because rugby 
athletes exhibit different movement patterns according to their playing position12 and because 
of reported differences in aerobic field test performance between playing positions.14 Previous 
associations of ACTN38 and FTO30 genotypes with playing position in similar populations, 
where the functional consequences of both SNPs are better understood, permits logical 
speculation regarding each association. However, lack of association of ACE and COL5A1 
SNPs with playing position8,9 demonstrates that although some SNPs may be advantageous to 
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certain positions, others may be more broadly associated with superior athletic ability in rugby 
players. Indeed, no genotypes were associated with rugby union performance variables in the 
present study, indicating that some SNPs are advantageous to general rugby union ability, but 
do not contribute to the number or success of key actions performed by individual athletes. In 
light of our finding that several in-game performance variables differ between forwards and 
backs (as expected), future studies should seek to determine whether other SNPs - including 
those previously associated with playing position in rugby8,30 - are associated with these or 
other performance variables relevant to that particular SNP. Despite the association of KCNH8 
with elite rugby status, the genotypes recorded in this study do not appear to differ between 
playing positions or relate to the frequency or success of specific playing actions. 
 
Practical Applications 
This study presents novel associations of the PRDM1 rs10499043 SNP with marathon 
performance and the KCNH8 rs4973706 SNP with the attainment of elite rugby union status, 
adding to a growing body of evidence surrounding the heritability of athletic traits and 
identifying polymorphisms that merit further examination. It is also important to note the 
limitations of this investigation. Firstly, assessing V̇O2max directly may have helped to 
determine whether the associations discovered in this study are linked to cardiorespiratory 
fitness, although from a practical perspective that is virtually impossible in large cohorts of 
high-level athletes. Secondly, only male Caucasians were investigated to control for the effects 
of sex and geographic ancestry. Accordingly, these findings should be replicated in women and 
participants with different ancestry. The present study included athletes from long-distance 
running and rugby union, meaning the influence of these SNPs in other sports remains 
unknown, and the lack of KCNH8 genotype data for all participants, particularly in runners, 
highlights the need for further investigation of this SNP in relation to athletic status and 
15 
 
performance. Most importantly, our results should be replicated in independent cohorts and 
different contexts before the investigated SNPs should be used in commercial genetic testing. 
 
Conclusions 
The present study is the first to demonstrate associations of the PRDM1 rs10499043 SNP with 
marathon running performance and the KCNH8 rs4973706 SNP with elite athlete status in 
rugby union. The alleles associated with superior performance and elite athlete status in the 
present study are the same as those previously associated with greater V̇O2max adaptation. 
This suggests that at least some SNPs, and thus physiological mechanisms that modulate the 
extent of training adaptations, are common to both untrained individuals and trained athletes. 
Further investigation is required to confirm whether the magnitude of cardiorespiratory training 
adaptation that occurs in elite runners and rugby athletes is genotype dependent.  
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Table 1. Characteristics of participants analysed for PRDM1, GRIN3A and sub-sample for KCNH8. 
Group n Age (y) Height (m) Mass (kg) BMI (kg/m2) 
Non-athletes      
PRDM1 & GRIN3A 355 27 (15) 1.79 (0.07) 78.0 (11.4)* 24.5 (3.5)* 
KCNH8 223 23 (7) 1.79 (0.06) 77.6 (11.8) 24.2 (3.3) 
Rugby Union      
PRDM1 & GRIN3A 212 28 (7) 1.86 (0.07)** 102.4 (11.4)** 29.7 (3.1)** 
KCNH8 139 26 (5) 1.86 (0.07)*** 102.8 (12.3)*** 29.7 (3.0)*** 
Runners      
PRDM1 & GRIN3A 165 36 (9) 1.76 (0.06) 66.9 (6.8) 21.0 (2.0) 
31. Data are mean (standard deviation) 
32. * greater than runners (p < 0.0005) 
33. ** greater than non-athletes and runners (p < 0.0005) 






















Table 2. Distribution of rugby athletes according to playing position. Data are number of athletes (% of all 
athletes) 
 Analysis of 
PRDM1 and GRIN3A 
Analysis of 
KCNH8 
 n = 212 n = 139 
Forwards vs. Backs   
Forwards 114 (53.8) 79 (56.8) 
Backs 98 (46.2) 60 (43.2) 
Positional sub-groups   
Front Five 66 (31.1) 47 (33.8) 
Back Row 50 (23.6) 34 (25.5) 
Half Backs 41 (19.3) 22 (15.8) 
Centres 27 (12.7) 18 (12.9) 























Table 3. Genotype distribution for PRDM1 and GRIN3A according to athlete group. Data are number of 
individuals (%) 
  Group  
SNP Genotype Non-athlete All athletes Rugby Runner Total MAF 
  n = 355 n = 377 n = 212 n = 165 n = 732 n = 732 
PRDM1 CC 282 (79.4) 284 (75.3) 163 (76.9) 121 (73.3) 566 (76.6) 0.12 
rs10499043 CT/TT 73 (20.6) 93 (24.7) 49 (23.1) 44 (26.7) 166 (23.4)  
        
GRIN3A GG 293 (82.5) 311 (82.5) 175 (82.6) 136 (82.4) 604 (82.5) 0.09 
rs1535628 GA/AA 62 (17.5) 66 (17.5) 37 (17.4) 29 (17.6) 128 (17.5)  
        


























Figure 1. KCNH8 rs4973706 genotype distribution in non-athletes and rugby athletes. * greater 







Figure 2. Runners’ PB marathon time according to PRDM1 rs10499043 genotype. * faster 
time than CC (p = 0.023). 
 
